What Happened

Greg Fahy, chief scientific officer at biotech companies Intervene Immune and 21st Century Medicine, recently completed his analysis of brain tissue samples from his deceased colleague L. Stephen Coles. The samples came from Coles’s brain, which has been stored at the Alcor cryonics facility in Arizona since 2014.

Fahy’s findings, published after more than a year of analysis, show the brain tissue is “astonishingly well preserved.” When the frozen samples were slowly rewarmed and rehydrated, the cellular structure “bounced back” with every microscopic detail intact. Crucially, Coles’s brain showed no signs of cracking—a major concern in large-scale cryopreservation that Coles himself was particularly curious about before his death.

The preservation used a vitrification process, which turns biological tissue into a glass-like state using cryoprotective chemicals. This prevents the formation of ice crystals that would normally destroy cellular structure during freezing.

Why It Matters

This research addresses a fundamental question that has plagued cryopreservation science: can large-scale human tissue maintain cellular integrity over extended periods? While vitrification has been successfully used for smaller biological materials like embryos and eggs for decades, preserving entire organs—especially something as complex as the human brain—has remained largely theoretical.

The findings have immediate practical applications beyond the cryonics industry. “We’re at the cusp” of using cryopreservation for organ transplantation, according to researchers quoted in the study. Currently, donated organs must be used within hours or days, severely limiting transplant opportunities. Successful long-term organ preservation could revolutionize organ banking and dramatically expand the pool of viable organs for patients.

For neuroscientists, this breakthrough offers a new research tool: access to well-preserved human brain tissue for study. This could accelerate research into neurological diseases and brain function in ways that animal models cannot fully replicate.

Background

L. Stephen Coles was a gerontologist who spent his career studying human longevity and aging. As a scientist deeply interested in cryogenics, he made the unusual decision to contribute to the field even after death by volunteering his own brain for preservation and study.

The science of cryopreservation faces enormous technical challenges when scaling up from microscopic samples to entire organs. Brain tissue is particularly difficult to preserve because of its size, density, and complex structure. The process requires toxic cryoprotectants and extremely uniform cooling to prevent damage—factors that become exponentially more difficult to control in larger tissues.

Previous attempts at large-scale tissue cryopreservation typically resulted in significant damage from ice crystal formation or thermal stress. This study represents the first detailed analysis showing that these challenges can be overcome with current vitrification techniques.

Recent supporting research from Germany has shown that mouse brain slices can not only be structurally preserved but can also recover electrical activity after cryopreservation, suggesting that functional preservation may be possible for research applications.

What’s Next

While Fahy expresses hope that structural preservation might eventually lead to “reanimation,” other experts remain skeptical about reviving consciousness from cryopreserved brains. John Bischof, a cryopreservation researcher at the University of Minnesota, emphasizes that “this brain is not alive,” highlighting the distinction between structural preservation and functional recovery.

The more immediate applications lie in organ transplantation and neuroscience research. Researchers suggest that cryopreserved organ banking could become reality within 5-10 years, potentially saving thousands of lives annually by extending the viable time window for organ matching and transport.

For the cryonics industry, these findings provide scientific validation of their preservation methods, though questions about consciousness revival remain unanswered. The research may attract more interest from those considering cryopreservation, while also informing improvements to current techniques.

Scientists will likely continue studying Coles’s brain and similar samples to better understand the limits and possibilities of long-term tissue preservation, gradually building the knowledge base needed for practical applications.